Search Results - "HERSTENSTEIN, B"

Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database by Saccardi, R, Kozak, T, Bocelli-Tyndall, C, Fassas, A, Kazis, A, Havrdova, E, Carreras, E, Saiz, A, Löwenberg, B, te Boekhorst, P AW, Gualandi, F, Openshaw, H, Longo, G, Pagliai, F, Massacesi, L, Deconink, E, Ouyang, J, Nagore, F JZ, Besalduch, J, Lisukov, I A, Bonini, A, Merelli, E, Slavin, S, Gratwohl, A, Passweg, J, Tyndall, A, Steck, A J, Andolina, M, Capobianco, M, Martin, J LD, Lugaresi, A, Meucci, G, Sáez, R A, Clark, R E, Fernandez, M N, Fouillard, L, Herstenstein, B, Koza, V, Cocco, E, Baurmann, H, Mancardi, G L

“…Over the last decade, hematopoietic stem cells transplantation (HSCT) has been increasingly used in the treatment of severe progressive autoimmune diseases. We…”
Get full text

European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching by DEVERGIE, A, APPERLEY, J. F, BACIGALUPO, A, EVENSEN, S. A, LJUNGMAN, P, DE WITTE, T, REIFFERS, J, NAGLER, A, CLARK, R. E, GOLDMAN, J. M, GRATWOHL, A, LABOPIN, M, MADRIGAL, A, JACOBSENS, N, CARRERAS, E, PRENTICE, H. G, JOUET, J. P, KOLB, H. J, HERSTENSTEIN, B

“…We have retrospectively analyzed the impact of prognostic factors on the outcome of serologically HLA-matched unrelated donor (UD) BMT for CML. For this…”
Get full text

European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation by Devergie, A, Apperley, J F, Labopin, M, Madrigal, A, Jacobsen, N, Carreras, E, Prentice, H G, Jouet, J P, Kolb, H J, Herstenstein, B, Bacigalupo, A, Evensen, S A, Ljungman, P, de Witte, T, Reiffers, J, Nagler, A, Clark, R E, Goldman, J M, Gratwohl, A

“…We have retrospectively analyzed the impact of prognostic factors on the outcome of serologically HLA-matched unrelated donor (UD) BMT for CML. For this…”
Get full text